Early risk factors for miscarriage: A prospective cohort study in pregnant women

Reproductive BioMedicine Online

Volumn 17, Issue 1, 2008, Pages 101-113

  Arck, Petra C ^a   Rücke, Mirjam ^a   Rose, Matthias ^b,g   Szekeres Bartho, Julia ^c   Douglas, Alison J ^d   Pritsch, Maria ^e   Blois, Sandra M ^a   Pincus, Maike K ^a   Bärenstrauch, Nina ^a   Dudenhausen, Joachim W ^a   Nakamura, Katrina ^f   Sheps, Sam ^f   Klapp, Burghard F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b QualityMetric Incorporated and Health Assessment Lab   (United States)

^c UNIVERSITY OF PÉCS   (Hungary)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Body mass index; Corticotrophin releasing hormone; Miscarriage; Progesterone; Risk analysis; Stress perception

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; PROGESTERONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION; STRESS; UNDERWEIGHT;

EID: 48249139472     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60300-8     Document Type: Article

References (57)

1. Al-Sebai MA, CR Kingsland, M Diver et al. 1995 The role of a single progesterone measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. British Journal of Obstetrics and Gynaecology 102, 364-369.
2. Arck P, Hansen PJ, Mulac Jericevic B et al. 2007 Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. American Journal of Reproductive Immunology 58, 268-279.
3. Bamberger CM, Minas V, Bamberger AM et al. 2007 Expression of urocortin in the extravillous human trophoblast at the implantation site. Placenta 28, 127-132.
4. Baptista T, Beaulieu S 2002 Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs? Canadian Journal of Psychiatry 47, 742-749.
5. Baulieu EE 1997 RU 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996. Annals of the New York Academy of Sciences 828, 47-58.
6. Blois SM, Ilarregui JM, Tometten M et al. 2007 A pivotal role for galectin-1 in fetomaternal tolerance. Nature Medicine 13, 1450-1457.
7. Blois SM, Joachim R, Kandil J et al. 2004 Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. Journal of Immunology 172, 5893-5899.
8. Boyles SH, Ness RB, Grisso JAA et al. 2000 Life event stress and the association with spontaneous abortion in gravid women at an urban emergency department. Health Psychology 19, 510-514.
9. Brannian JD, Schmidt SM, Kreger DO et al. 2001 Baseline non-fasting serum leptin concentration to body mass index ratio is predictive of IVF outcomes. Human Reproduction 16, 1819-1826.
10. Bulletti C, Flamigni C, Giacomucci E 1996 Reproductive failure due to spontaneous abortion and recurrent miscarriage. Human Reproduction Update 2, 118-136
11. Casabiell X, Pineiro V, Vega F et al. 2001 Leptin, reproduction and sex steroids. Pituitary 4, 93-99.
12. Christiansen OB, Nielsen HS, Kolte AM 2006 Future directions of failed implantation and recurrent miscarriage research. Reproductive BioMedicine Online 13, 71-83.
13. Cnattingius S, Signorello LB, Anneren G et al. 2000 Caffeine intake and the risk of first-trimester spontaneous abortion. New England Journal of Medicine 343, 1839-1845.
14. Csapo AI, Pinto-Dantas CA 1965 The effect of progesterone on the human uterus. Proceedings of the National Academy of Sciences of the USA 54, 1069-1076.
15. Daya S 1996 Evaluation and management of recurrent spontaneous abortion. Current Opinion in Obstetrics and Gynecology 8, 188-192.
16. Di Renzo GC, Mattei A, Gojnic M et al. 2005 Progesterone and pregnancy. Current Opinion in Obstetrics and Gynecology 17, 598-600.
17. Elsenbruch S, Benson S, Rucke M et al. 2007 Social support during pregnancy: effects on maternal depressive symptoms, smoking and pregnancy outcome. Human Reproduction 22, 869-877.
18. Fliege H, Rose M, Arck P et al. 2005 The Perceived Stress Questionnaire (PSQ) reconsidered: validation and reference values from different clinical and healthy adult samples. Psychosomatic Medicine 67, 78-88.
19. Fydrich T, Geyer, M, Hessel A et al. 1999 Fragebogen zur sozialen Unterstützung (F-SOZU): Neue Ergebnisse zur Testgüte und Normierung an einer repräsentativen Stichprobe. Diagnostica 45, 212-216.
20. Gruber CJ, Huber JC 2005 The role of dydrogesterone in recurrent (habitual) abortion. Journal of Steroid Biochemistry and Molecular Biology 97, 426-430.
21. Hannes, M, J Englert, W Gotlieb et al. 1992 Recurrent spontaneous miscarriage. Revue Médicale de Bruxelles 13, 103-106.
22. Hautzinger M, Bailer M 1993 Allgemeine Depressionsskala. Beltz Test GmbH, Weinheim, Germany.
23. Heffner LJ 2004 Advanced maternal age - how old is too old? New England Journal of Medicine 351, 1927-1929.
24. Helgstrand S, Andersen AM 2005 Maternal underweight and the risk of spontaneous abortion. Acta Obstetrica et Gynecologica Scandinavica 84, 1197-1201.
25. Hosmer D, Lemeshow S 1989 Applied logistic regression. John Wiley and Sons, New York.
26. Ioannidis G, Sacks G, Reddy N et al. 2005 Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study. Human Reproduction 20, 741-746.
27. Itskovitz J, Hodgen GD 1988 Endocrine basis for the initiation, maintenance and termination of pregnancy in humans. Psychoneuroendocrinology 13, 155-170.
28. Iyer P, Wani L, Joshi S et al. 2007 Cytogenetic investigations in couples with repeated miscarriages and malformed children: report of a novel insertion. Reproductive BioMedicine Online 14, 314-321.
29. Joachim R, Zenclussen AC, Polgar B et al. 2003 The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids 68, 931-940.
30. Johns J, Muttukrishna S, Lygnos M et al. 2007 Maternal serum hormone levels for prediction of adverse outcome in threatened miscarriage. Reproductive BioMedicine Online 15, 413-421.
31. Kalinka J, Szekeres-Bartho J 2005 The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion. American Journal of Reproductive Immunolology 53, 166-171.
32. Kivimaki M, Head J, Ferrie JE et al. 2006 Work stress, weight gain and weight loss: evidence for bidirectional effects of job strain on body mass index in the Whitehall II study. International Journal of Obesity 30, 982-987.
33. Lage M, Garcia-Mayor RV, Tome MA et al. 1999 Serum leptin levels in women throughout pregnancy and the postpartum period and in women suffering spontaneous abortion. Clinical Endocrinology 50, 211-216.
34. Levenstein S, Prantera C, Varvo V et al. 1993 Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research. Journal of Psychosomatic Research 37, 19-32.
35. Maconochie N, Doyle P, Prior S et al. 2007 Risk factors for first trimester miscarriage - results from a UK-population-based case-control study. BJOG: An International Journal of Obstetrics and Gynaecology 114, 170-186.
36. Magiakou MA, Mastorakos G, Webster E et al. 1997 The hypothalamic-pituitary-adrenal axis and the female reproductive system. Annals of the New York Academy of Sciences 816, 42-56.
37. Nardo LG, Sallam HN 2006 Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles. Reproductive BioMedicine Online 13, 47-57.
38. Nelson DB, Grisso JA, Joffe MM et al. 2003 Does stress influence early pregnancy loss? Annals of Epidemiology 13, 223-229.
39. Nepomnaschy PA, Sheiner E, Mastorakos G et al. 2007 Stress, immune function and women's reproduction. Annals of the New York Academy of Sciences 1113, 350-364.
40. Nepomnaschy PA, Welch KB, McConnell DS et al. 2006 Cortisol levels and very early pregnancy loss in humans. Proceedings of the National Academy of Sciences of the USA 103, 3938-3942.
41. Neugebauer R, Kline J, Stein Z et al. 1996 Association of stressful life events with chromosomally normal spontaneous abortion. American Journal of Epidemiology 143, 588-596.
42. Norwitz ER, Schust DJ, Fisher SJ 2001 Implantation and the survival of early pregnancy. New England Journal of Medicine 345, 1400-1408.
43. Oates-Whitehead RM, Haas DM, Carrier JA 2003 Progestogen for preventing miscarriage. Cochrane Database of Systematic Reviews 4, CD003511.
44. Padgett DA, Glaser R 2003 How stress influences the immune response. Trends in Immunology 24, 444-448.
45. Piccinni MP 2006 T cells in normal pregnancy and recurrent pregnancy loss. Reproductive BioMedicine Online 13, 840-844.
46. Piekorz RP, Gingras S, Hoffmeyer A et al. 2003 Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20alpha-hydroxysteroid dehydrogenase. Molecular Endocrinology 19, 431-440.
47. Red-Horse K, Zhou Y, Genbacev O et al. 2004 Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. Journal of Clinical Investigation 114, 744-754.
48. Schindler AE 2005 Endocrinology of pregnancy: consequences for the diagnosis and treatment of pregnancy disorders. Journal of Steroid Biochemistry and Molecular Biology 97, 386-388.
49. Stern JJ, Dorfmann AD, Gutierrez-Najar AJ et al. 1996 Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertility and Sterility 65, 250-253.
50. Sthoeger ZM, Mozes E, Tartakovsky B 1993 Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proceedings of the National Academy of Sciences of the USA 90, 6464-6467.
51. Stray-Pedersen BS, Stray-Pedersen PS 1984 Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. American Journal of Obstetrics and Gynecology 148, 140-146.
52. Szekeres-Bartho J, Barakonyi A, Par G et al. 2001. Progesterone as an immunomodulatory molecule. International Immunopharmacology 1, 1037-1048.
53. te Velde ER, Pearson PL 2002 The variability of female reproductive ageing. Human Reproduction 8, 141-154.
54. Wahabi H, Abed Althagafi N, Elawad M. 2007 Progestogen for treating threatened miscarriage. Cochrane Database of Systematic Reviews 18, CD005943.
55. Ware JE, Jr. 2003 Conceptualization and measurement of health-related quality of life: comments on an evolving field. Archives of Physical Medicine and Rehabilitation 84, 43-51.
56. Wiebold JL, Stanfield PH, Becker WC et al. 1986 The effect of restraint stress in early pregnancy in mice. Journal of Reproduction and Fertility 78, 185-192.
57. Wilcox AJ, Baird D, Weinberg CR 1999 Time of implantation of the conceptus and loss of pregnancy. New England Journal of Medicine 340, 1796-1799.